1

Enovis

#3757

Rank

$2.64B

Marketcap

US United States

Country

Enovis
Leadership team

Mr. Mitchell P. Rales (Co-Founder & Independent Chairman)

Mr. Matthew L. Trerotola (CEO & Director)

Mr. Brady R. Shirley (Pres, COO & Director)

Products/ Services
Health Care
Number of Employees
1,000 - 20,000
Headquarters
Wilmington, Delaware, United States
Established
2022
Company Registration
SEC CIK number: 0001420800
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
ENOV
Social Media
Overview
Location
Summary
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
History

Enovis began in the mid 1980s as an engineering firm providing solutions to customers in the automotive and aerospace industries. In the late 1990s, Enovis expanded its expertise to the healthcare and energy sectors and developed a number of ground-breaking products and services. Today, Enovis is a leading provider of healthcare and energy solutions, working with customers around the world.

Mission
At Enovis, we are committed to developing and delivering innovative, reliable, and sustainable solutions that improve the quality of life for all our customers.
Vision
Enovis strives to be a leading global provider of healthcare and energy solutions, improving the quality of people's lives through innovative products and services.
Key Team

Mr. Christopher M. Hix (Exec. VP of Fin. & CFO)

Mr. Daniel A. Pryor (Exec. VP of Strategy & Bus. Devel.)

Mr. John Kleckner (Principal Accounting Officer)

Mr. Michael S. Macek (VP of Fin. & Investor Relations)

Mr. Bradley J. Tandy (Sr. VP & Gen. Counsel)

Katie Sweet (VP of Corp. Communication)

Ms. Patricia A. Lang (Sr. VP & Chief HR Officer)

Recognition and Awards
Enovis has been recognised for its achievements with a number of awards, including the 2010 Global Energy Award from the United Nations and the 2011 World Technology Award from the World Technology Network.
References
Enovis
Leadership team

Mr. Mitchell P. Rales (Co-Founder & Independent Chairman)

Mr. Matthew L. Trerotola (CEO & Director)

Mr. Brady R. Shirley (Pres, COO & Director)

Products/ Services
Health Care
Number of Employees
1,000 - 20,000
Headquarters
Wilmington, Delaware, United States
Established
2022
Company Registration
SEC CIK number: 0001420800
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
ENOV
Social Media